Literature DB >> 8870760

Systemic toxicity from ocular homatropine.

K M Reilly1, L Chan, N J Mehta, R F Salluzzo.   

Abstract

Toxidromes are well known to emergency physicians. An unclear or incomplete history and subtle findings on physical examination make the diagnosis of poisonings challenging. This article reports a patient who had an acute onset of visual hallucinations, pressured speech, and mania. Although she denied taking any medications, she was ultimately diagnosed as having anticholinergic toxicity. On further questioning of family members, it was discovered that she was being treated for anterior uveitis with 5% homatropine. This case illustrates the potential role of ocular medications in systemic toxicity. Patients often do not consider eyedrops to be medications, and their use may be overlooked in the medical history. It also is important to educate patients and medical staff in methods to minimize systemic toxicity when using ocular medication.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8870760     DOI: 10.1111/j.1553-2712.1996.tb03533.x

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  1 in total

1.  Intramuscular ophthalmic homatropine vs. atropine to prevent lethality in rates with dichlorvos poisoning.

Authors:  Sean M Bryant; Brandon K Wills; James W Rhee; Steven E Aks; Gerald Maloney
Journal:  J Med Toxicol       Date:  2006-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.